Contributors: [Blasi A] Servei d’Anestèsia, Hospital Clínic de Barcelona, Barcelona, Spain. Ciber de Malalties Hepàtiques i Digestives (CIBEREHD), Madrid, Spain. Institut d'Investigacions Biomèdiques August Pi-Sunyer (IDIBAPS), Barcelona, Spain. [Machlab S, Costa-Seixas JP] Servei de Malalties Digestives, Corporació Sanitària Universitària Parc Taulí, Sabadell, Spain. Institut d'Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Risco R] Servei d’Anestèsia, Hospital Clínic de Barcelona, Barcelona, Spain. [Hernández-Cely G] Servei de Gastroenterologia i Hepatologia, Fundació Cardioinfantil, Colombia. Unitat 6GI, Institut de Malalties Digestives i Metabòliques, Hospital Clínic de Barcelona, Barcelona, Spain. [Horta D] Servei de Gastroenterologia, Hospital Universitari Mutua de Terrassa, Terrassa, Spain. [Profitos J] Servei de Gastroenterologia, Hospital de Terrassa, Consorci Sanitari de Terrassa, Terrassa, Spain; Consorci Sanitari de Terrassa
نبذة مختصرة : Prophylactic administration of platelets and fresh frozen plasma (FFP) has been recommended in patients with cirrhosis with low platelets and/or prolonged international normalized ratio (INR) without scientific evidence to support this practice. In this analysis, we evaluated the use of prophylactic administration of blood products in outpatients with cirrhosis undergoing endoscopic band ligation (EBL).This is a multicenter retrospective analysis of consecutive EBL procedures in patients with cirrhosis at 4 hospitals in Spain from 01/2010-01/2017. FFP and/or platelet transfusion were given at the discretion of the physician if INR was >1.5 and/or platelet count
No Comments.